XML 51 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:    
Net income $ 78,710 $ 99,293
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 25,245 25,351
Deferred income taxes 2,927 6,728
Share-based compensation expense related to equity incentive plans 9,986 9,024
Excess tax benefit from share-based compensation (20) (385)
Convertible debt derivatives - revaluation and amortization 330 (30)
Amortization of convertible debenture issuance costs 54 55
Amortization of debt discount on convertible debentures 1,975 1,805
Losses on equity method investments 121 61
Unrealized impairment loss on available-for-sale investments 0 945
Changes in operating assets and liabilities:    
Increase in accounts receivable (2,814) (15,052)
Decrease (increase) in inventories 316 (21,384)
Increase in deferred income on shipments to distributors 2,084 5,554
Increase (decrease) in accounts payable and accrued liabilities 4,766 (17,787)
Change in other assets and liabilities 5,291 (10,873)
Net cash provided by operating activities 128,971 83,305
Cash flows from investing activities:    
Purchases of available-for-sale investments (29,130) (324,893)
Sales and maturities of available-for-sale investments 139,439 264,485
Business acquisitions (20,556) 0
Investment in other assets (1,609) (976)
Proceeds from sale of assets 50 0
Capital expenditures (10,304) (27,219)
Net cash provided by (used in) investing activities 77,890 (88,603)
Cash flows from financing activities:    
Payment of cash dividend (67,749) (65,900)
Proceeds from sale of common stock 4,961 18,272
Excess tax benefit from share-based compensation 20 385
Net cash used in financing activities (62,768) (47,243)
Net increase (decrease) in cash and cash equivalents 144,093 (52,541)
Cash and cash equivalents at beginning of period 635,755 703,924
Cash and cash equivalents at end of period $ 779,848 $ 651,383